341 related articles for article (PubMed ID: 17803437)
1. Zinc phthalocyanine tetrasulfonate (ZnPcS4): a new photosensitizer for photodynamic therapy in choroidal neovascularization.
Huang Y; Xu G; Peng Y; Lin H; Zheng X; Xie M
J Ocul Pharmacol Ther; 2007 Aug; 23(4):377-86. PubMed ID: 17803437
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy of experimental choroidal neovascularization with a hydrophilic photosensitizer: mono-L-aspartyl chlorin e6.
Mori K; Yoneya S; Anzail K; Kabasawa S; Sodeyama T; Peyman GA; Moshfeghi DM
Retina; 2001; 21(5):499-508. PubMed ID: 11642380
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic effects of ZnPcS(4)-BSA in human retinal pigment epithelium cells.
Huang Y; Xu G; Peng Y; Chen S; Wu Y
J Ocul Pharmacol Ther; 2009 Jun; 25(3):231-8. PubMed ID: 19456258
[TBL] [Abstract][Full Text] [Related]
4. Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2.
Renno RZ; Terada Y; Haddadin MJ; Michaud NA; Gragoudas ES; Miller JW
Arch Ophthalmol; 2004 Jul; 122(7):1002-11. PubMed ID: 15249365
[TBL] [Abstract][Full Text] [Related]
5. Verteporfin photodynamic therapy in the rat model of choroidal neovascularization: angiographic and histologic characterization.
Zacks DN; Ezra E; Terada Y; Michaud N; Connolly E; Gragoudas ES; Miller JW
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2384-91. PubMed ID: 12091441
[TBL] [Abstract][Full Text] [Related]
6. Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment.
Husain D; Kramer M; Kenny AG; Michaud N; Flotte TJ; Gragoudas ES; Miller JW
Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2322-31. PubMed ID: 10476799
[TBL] [Abstract][Full Text] [Related]
7. Selective occlusion of choroidal neovascularization by photodynamic therapy with a water-soluble photosensitizer, ATX-S10.
Obana A; Gohto Y; Kaneda K; Nakajima S; Takemura T; Miki T
Lasers Surg Med; 1999; 24(3):209-22. PubMed ID: 10229152
[TBL] [Abstract][Full Text] [Related]
8. PDT to monkey CNV with ATX-S10(Na): inappropriateness of early laser irradiation for selective occlusion.
Obana A; Gohto Y; Kaneda K; Nakajima S; Miki T
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2639-45. PubMed ID: 11581211
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the new photosensitizer Stakel (WST-11) for photodynamic choroidal vessel occlusion in rabbit and rat eyes.
Berdugo M; Bejjani RA; Valamanesh F; Savoldelli M; Jeanny JC; Blanc D; Ficheux H; Scherz A; Salomon Y; BenEzra D; Behar-Cohen F
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1633-44. PubMed ID: 18385085
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy of experimental choroidal neovascularization in the mouse.
Odergren A; Ming Y; Kvanta A
Curr Eye Res; 2006 Sep; 31(9):765-74. PubMed ID: 16966149
[TBL] [Abstract][Full Text] [Related]
11. Effects of photodynamic therapy using hematoporphyrin monomethyl ether on experimental choroidal neovascularization.
Fan S; Qiu H; Huang H; Gu Y; Zeng J
Photochem Photobiol; 2010; 86(4):972-80. PubMed ID: 20553408
[TBL] [Abstract][Full Text] [Related]
12. [Novel approach for management of age-related macular degeneration--antiangiogenic therapy and retinal regenerative therapy].
Tamaki Y
Nippon Ganka Gakkai Zasshi; 2007 Mar; 111(3):232-68; discussion 269. PubMed ID: 17402564
[TBL] [Abstract][Full Text] [Related]
13. Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys.
Kramer M; Miller JW; Michaud N; Moulton RS; Hasan T; Flotte TJ; Gragoudas ES
Ophthalmology; 1996 Mar; 103(3):427-38. PubMed ID: 8600419
[TBL] [Abstract][Full Text] [Related]
14. Scanning laser system for photodynamic therapy of choroidal neovascularization.
Obana A; Gohto Y
Lasers Surg Med; 2002; 30(5):370-5. PubMed ID: 12116330
[TBL] [Abstract][Full Text] [Related]
15. Selective photodynamic effects of the new photosensitizer ATX-S10(Na) on choroidal neovascularization in monkeys.
Obana A; Gohto Y; Kanai M; Nakajima S; Kaneda K; Miki T
Arch Ophthalmol; 2000 May; 118(5):650-8. PubMed ID: 10815157
[TBL] [Abstract][Full Text] [Related]
16. Angiographic and histologic effects of fundus photodynamic therapy with a hydrophilic sensitizer (mono-L-aspartyl chlorin e6).
Mori K; Yoneya S; Ohta M; Sano A; Anzai K; Peyman GA; Moshfeghi DM
Ophthalmology; 1999 Jul; 106(7):1384-91. PubMed ID: 10406627
[TBL] [Abstract][Full Text] [Related]
17. Reduced photoreceptor damage after photodynamic therapy through blockade of nitric oxide synthase in a model of choroidal neovascularization.
She H; Nakazawa T; Matsubara A; Hisatomi T; Young TA; Michaud N; Connolly E; Hafezi-Moghadam A; Gragoudas ES; Miller JW
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2268-77. PubMed ID: 17460290
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of photopoint photosensitizer mv6401, indium chloride methyl pyropheophorbide, as a photodynamic therapy agent in primate choriocapillaris and laser-induced choroidal neovascularization.
Ciulla TA; Criswell MH; Danis RP; Snyder WJ; Small W
Retina; 2004 Aug; 24(4):521-9. PubMed ID: 15300072
[TBL] [Abstract][Full Text] [Related]
19. Oxygen dependence of two-photon activation of zinc and copper phthalocyanine tetrasulfonate in Jurkat cells.
Mir Y; van Lier JE; Paquette B; Houde D
Photochem Photobiol; 2008; 84(5):1182-6. PubMed ID: 18331397
[TBL] [Abstract][Full Text] [Related]
20. Phthalocyanine photodynamic therapy: new strategy for closure of choroidal neovascularization.
Kliman GH; Puliafito CA; Stern D; Borirakchanyavat S; Gregory WA
Lasers Surg Med; 1994; 15(1):2-10. PubMed ID: 7527887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
